Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Inventory (2018 - 2025)

TransMedics (TMDX) has 8 years of Inventory data on record, last reported at $48.9 million in Q4 2025.

  • For Q4 2025, Inventory rose 5.0% year-over-year to $48.9 million; the TTM value through Dec 2025 reached $48.9 million, up 5.0%, while the annual FY2025 figure was $48.9 million, 5.0% up from the prior year.
  • Inventory reached $48.9 million in Q4 2025 per TMDX's latest filing, up from $44.5 million in the prior quarter.
  • Across five years, Inventory topped out at $52.2 million in Q3 2024 and bottomed at $11.8 million in Q1 2021.
  • Average Inventory over 5 years is $31.9 million, with a median of $34.7 million recorded in 2023.
  • Peak YoY movement for Inventory: surged 114.68% in 2023, then decreased 20.14% in 2025.
  • A 5-year view of Inventory shows it stood at $14.9 million in 2021, then surged by 38.67% to $20.6 million in 2022, then soared by 114.68% to $44.2 million in 2023, then grew by 5.24% to $46.6 million in 2024, then grew by 5.0% to $48.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $48.9 million in Q4 2025, $44.5 million in Q3 2025, and $38.9 million in Q2 2025.